Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine

The self-controlled tree-temporal scan statistic allows detection of potential vaccine- or drug-associated adverse events without prespecifying the specific events or postexposure risk intervals of concern. It thus opens a promising new avenue for safety studies. The method has been successfully use...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of epidemiology 2019-07, Vol.188 (7), p.1383-1388
Hauptverfasser: Yih, W Katherine, Kulldorff, Martin, Dashevsky, Inna, Maro, Judith C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1388
container_issue 7
container_start_page 1383
container_title American journal of epidemiology
container_volume 188
creator Yih, W Katherine
Kulldorff, Martin
Dashevsky, Inna
Maro, Judith C
description The self-controlled tree-temporal scan statistic allows detection of potential vaccine- or drug-associated adverse events without prespecifying the specific events or postexposure risk intervals of concern. It thus opens a promising new avenue for safety studies. The method has been successfully used to evaluate the safety of 2 vaccines for adolescents and young adults, but its suitability to study vaccines for older adults had not been established. The present study applied the method to assess the safety of live attenuated herpes zoster vaccination during 2011-2017 in US adults aged ≥60 years, using claims data from Truven Health MarketScan Research Databases. Counts of International Classification of Diseases diagnosis codes recorded in emergency department or hospital settings were scanned for any statistically unusual clustering within a hierarchical tree structure of diagnoses and within 42 days after vaccination. Among 1.24 million vaccinations, 4 clusters were found: cellulitis on days 1-3, nonspecific erythematous condition on days 2-4, "other complications . . ." on days 1-3, and nonspecific allergy on days 1-6. These results are consistent with local injection-site reactions and other known, generally mild, vaccine-associated adverse events and a favorable safety profile. This method might be useful for assessing the safety of other vaccines for older adults.
doi_str_mv 10.1093/aje/kwz104
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2232130951</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2429047036</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-a0e1e9e795c68710a4fca12021711212d57b99e0711e8e6bb865d87f16e6cf3a3</originalsourceid><addsrcrecordid>eNpdkU1LAzEQhoMoWj8u_gAJeBFhdSbZzW6OpfgFBQ-tHrwsaTqrW7ebmmSV-utdqXrwNAw878MwL2PHCBcIWl6aBV2-fnwipFtsgGmuEiUytc0GACASLZTYY_shLAAQdQa7bE8iKFGkMGDxIdTtM48vxCfUVMnItdG7pqE5n3qiZErLlfOm4RNrWj6JJtYh1pZHx4chUAibqKkorrmr-Lh-Jz6MkdrOxF5yS35FgT-5EMnzR2Nt3dIh26lME-joZx6wh-ur6eg2Gd_f3I2G48RKzGJigJA05TqzqsgRTFpZgwIE5ogCxTzLZ1oT9BsVpGazQmXzIq9QkbKVNPKAnW28K-_eOgqxXNbBUtOYllwXSiGkQAk6wx49_YcuXOfb_rpSpEJDmoNUPXW-oax3IXiqypWvl8avS4Tyu4uy76LcdNHDJz_Kbrak-R_6-3z5BS01hNM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2429047036</pqid></control><display><type>article</type><title>Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Yih, W Katherine ; Kulldorff, Martin ; Dashevsky, Inna ; Maro, Judith C</creator><creatorcontrib>Yih, W Katherine ; Kulldorff, Martin ; Dashevsky, Inna ; Maro, Judith C</creatorcontrib><description>The self-controlled tree-temporal scan statistic allows detection of potential vaccine- or drug-associated adverse events without prespecifying the specific events or postexposure risk intervals of concern. It thus opens a promising new avenue for safety studies. The method has been successfully used to evaluate the safety of 2 vaccines for adolescents and young adults, but its suitability to study vaccines for older adults had not been established. The present study applied the method to assess the safety of live attenuated herpes zoster vaccination during 2011-2017 in US adults aged ≥60 years, using claims data from Truven Health MarketScan Research Databases. Counts of International Classification of Diseases diagnosis codes recorded in emergency department or hospital settings were scanned for any statistically unusual clustering within a hierarchical tree structure of diagnoses and within 42 days after vaccination. Among 1.24 million vaccinations, 4 clusters were found: cellulitis on days 1-3, nonspecific erythematous condition on days 2-4, "other complications . . ." on days 1-3, and nonspecific allergy on days 1-6. These results are consistent with local injection-site reactions and other known, generally mild, vaccine-associated adverse events and a favorable safety profile. This method might be useful for assessing the safety of other vaccines for older adults.</description><identifier>ISSN: 0002-9262</identifier><identifier>EISSN: 1476-6256</identifier><identifier>DOI: 10.1093/aje/kwz104</identifier><identifier>PMID: 31062840</identifier><language>eng</language><publisher>United States: Oxford Publishing Limited (England)</publisher><subject>Adolescents ; Adults ; Aged ; Allergies ; Cellulitis ; Clustering ; Complications ; Data Mining ; Drug-Related Side Effects and Adverse Reactions - epidemiology ; Emergency medical care ; Emergency medical services ; Female ; Herpes zoster ; Herpes Zoster - epidemiology ; Herpes Zoster - prevention &amp; control ; Herpes Zoster Vaccine - adverse effects ; Humans ; Immunization ; Male ; Middle Aged ; Older people ; Patient Safety ; Research design ; Safety ; Structural hierarchy ; United States - epidemiology ; Vaccines ; Vaccines, Attenuated - adverse effects ; Young adults</subject><ispartof>American journal of epidemiology, 2019-07, Vol.188 (7), p.1383-1388</ispartof><rights>The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-a0e1e9e795c68710a4fca12021711212d57b99e0711e8e6bb865d87f16e6cf3a3</citedby><cites>FETCH-LOGICAL-c315t-a0e1e9e795c68710a4fca12021711212d57b99e0711e8e6bb865d87f16e6cf3a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31062840$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yih, W Katherine</creatorcontrib><creatorcontrib>Kulldorff, Martin</creatorcontrib><creatorcontrib>Dashevsky, Inna</creatorcontrib><creatorcontrib>Maro, Judith C</creatorcontrib><title>Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine</title><title>American journal of epidemiology</title><addtitle>Am J Epidemiol</addtitle><description>The self-controlled tree-temporal scan statistic allows detection of potential vaccine- or drug-associated adverse events without prespecifying the specific events or postexposure risk intervals of concern. It thus opens a promising new avenue for safety studies. The method has been successfully used to evaluate the safety of 2 vaccines for adolescents and young adults, but its suitability to study vaccines for older adults had not been established. The present study applied the method to assess the safety of live attenuated herpes zoster vaccination during 2011-2017 in US adults aged ≥60 years, using claims data from Truven Health MarketScan Research Databases. Counts of International Classification of Diseases diagnosis codes recorded in emergency department or hospital settings were scanned for any statistically unusual clustering within a hierarchical tree structure of diagnoses and within 42 days after vaccination. Among 1.24 million vaccinations, 4 clusters were found: cellulitis on days 1-3, nonspecific erythematous condition on days 2-4, "other complications . . ." on days 1-3, and nonspecific allergy on days 1-6. These results are consistent with local injection-site reactions and other known, generally mild, vaccine-associated adverse events and a favorable safety profile. This method might be useful for assessing the safety of other vaccines for older adults.</description><subject>Adolescents</subject><subject>Adults</subject><subject>Aged</subject><subject>Allergies</subject><subject>Cellulitis</subject><subject>Clustering</subject><subject>Complications</subject><subject>Data Mining</subject><subject>Drug-Related Side Effects and Adverse Reactions - epidemiology</subject><subject>Emergency medical care</subject><subject>Emergency medical services</subject><subject>Female</subject><subject>Herpes zoster</subject><subject>Herpes Zoster - epidemiology</subject><subject>Herpes Zoster - prevention &amp; control</subject><subject>Herpes Zoster Vaccine - adverse effects</subject><subject>Humans</subject><subject>Immunization</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Older people</subject><subject>Patient Safety</subject><subject>Research design</subject><subject>Safety</subject><subject>Structural hierarchy</subject><subject>United States - epidemiology</subject><subject>Vaccines</subject><subject>Vaccines, Attenuated - adverse effects</subject><subject>Young adults</subject><issn>0002-9262</issn><issn>1476-6256</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1LAzEQhoMoWj8u_gAJeBFhdSbZzW6OpfgFBQ-tHrwsaTqrW7ebmmSV-utdqXrwNAw878MwL2PHCBcIWl6aBV2-fnwipFtsgGmuEiUytc0GACASLZTYY_shLAAQdQa7bE8iKFGkMGDxIdTtM48vxCfUVMnItdG7pqE5n3qiZErLlfOm4RNrWj6JJtYh1pZHx4chUAibqKkorrmr-Lh-Jz6MkdrOxF5yS35FgT-5EMnzR2Nt3dIh26lME-joZx6wh-ur6eg2Gd_f3I2G48RKzGJigJA05TqzqsgRTFpZgwIE5ogCxTzLZ1oT9BsVpGazQmXzIq9QkbKVNPKAnW28K-_eOgqxXNbBUtOYllwXSiGkQAk6wx49_YcuXOfb_rpSpEJDmoNUPXW-oax3IXiqypWvl8avS4Tyu4uy76LcdNHDJz_Kbrak-R_6-3z5BS01hNM</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Yih, W Katherine</creator><creator>Kulldorff, Martin</creator><creator>Dashevsky, Inna</creator><creator>Maro, Judith C</creator><general>Oxford Publishing Limited (England)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T2</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20190701</creationdate><title>Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine</title><author>Yih, W Katherine ; Kulldorff, Martin ; Dashevsky, Inna ; Maro, Judith C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-a0e1e9e795c68710a4fca12021711212d57b99e0711e8e6bb865d87f16e6cf3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescents</topic><topic>Adults</topic><topic>Aged</topic><topic>Allergies</topic><topic>Cellulitis</topic><topic>Clustering</topic><topic>Complications</topic><topic>Data Mining</topic><topic>Drug-Related Side Effects and Adverse Reactions - epidemiology</topic><topic>Emergency medical care</topic><topic>Emergency medical services</topic><topic>Female</topic><topic>Herpes zoster</topic><topic>Herpes Zoster - epidemiology</topic><topic>Herpes Zoster - prevention &amp; control</topic><topic>Herpes Zoster Vaccine - adverse effects</topic><topic>Humans</topic><topic>Immunization</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Older people</topic><topic>Patient Safety</topic><topic>Research design</topic><topic>Safety</topic><topic>Structural hierarchy</topic><topic>United States - epidemiology</topic><topic>Vaccines</topic><topic>Vaccines, Attenuated - adverse effects</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yih, W Katherine</creatorcontrib><creatorcontrib>Kulldorff, Martin</creatorcontrib><creatorcontrib>Dashevsky, Inna</creatorcontrib><creatorcontrib>Maro, Judith C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yih, W Katherine</au><au>Kulldorff, Martin</au><au>Dashevsky, Inna</au><au>Maro, Judith C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine</atitle><jtitle>American journal of epidemiology</jtitle><addtitle>Am J Epidemiol</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>188</volume><issue>7</issue><spage>1383</spage><epage>1388</epage><pages>1383-1388</pages><issn>0002-9262</issn><eissn>1476-6256</eissn><abstract>The self-controlled tree-temporal scan statistic allows detection of potential vaccine- or drug-associated adverse events without prespecifying the specific events or postexposure risk intervals of concern. It thus opens a promising new avenue for safety studies. The method has been successfully used to evaluate the safety of 2 vaccines for adolescents and young adults, but its suitability to study vaccines for older adults had not been established. The present study applied the method to assess the safety of live attenuated herpes zoster vaccination during 2011-2017 in US adults aged ≥60 years, using claims data from Truven Health MarketScan Research Databases. Counts of International Classification of Diseases diagnosis codes recorded in emergency department or hospital settings were scanned for any statistically unusual clustering within a hierarchical tree structure of diagnoses and within 42 days after vaccination. Among 1.24 million vaccinations, 4 clusters were found: cellulitis on days 1-3, nonspecific erythematous condition on days 2-4, "other complications . . ." on days 1-3, and nonspecific allergy on days 1-6. These results are consistent with local injection-site reactions and other known, generally mild, vaccine-associated adverse events and a favorable safety profile. This method might be useful for assessing the safety of other vaccines for older adults.</abstract><cop>United States</cop><pub>Oxford Publishing Limited (England)</pub><pmid>31062840</pmid><doi>10.1093/aje/kwz104</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9262
ispartof American journal of epidemiology, 2019-07, Vol.188 (7), p.1383-1388
issn 0002-9262
1476-6256
language eng
recordid cdi_proquest_miscellaneous_2232130951
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adolescents
Adults
Aged
Allergies
Cellulitis
Clustering
Complications
Data Mining
Drug-Related Side Effects and Adverse Reactions - epidemiology
Emergency medical care
Emergency medical services
Female
Herpes zoster
Herpes Zoster - epidemiology
Herpes Zoster - prevention & control
Herpes Zoster Vaccine - adverse effects
Humans
Immunization
Male
Middle Aged
Older people
Patient Safety
Research design
Safety
Structural hierarchy
United States - epidemiology
Vaccines
Vaccines, Attenuated - adverse effects
Young adults
title Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T08%3A23%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Using%20the%20Self-Controlled%20Tree-Temporal%20Scan%20Statistic%20to%20Assess%20the%20Safety%20of%20Live%20Attenuated%20Herpes%20Zoster%20Vaccine&rft.jtitle=American%20journal%20of%20epidemiology&rft.au=Yih,%20W%20Katherine&rft.date=2019-07-01&rft.volume=188&rft.issue=7&rft.spage=1383&rft.epage=1388&rft.pages=1383-1388&rft.issn=0002-9262&rft.eissn=1476-6256&rft_id=info:doi/10.1093/aje/kwz104&rft_dat=%3Cproquest_cross%3E2429047036%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2429047036&rft_id=info:pmid/31062840&rfr_iscdi=true